Literally a large number of cancer patients are not claiming benefits to which they are entitled.

There’s large variation in take-up across the UK. Scotland gets the lowest claim price overall – 64 per cent do not claim. Someone living with tumor in Northern Ireland can be more than twice as likely to claim as someone living with malignancy in Scotland. Low take-up of disability benefits by people affected by cancer is due to issues like the perceived stigma of declaring benefits from the condition and the complicated and confusing claiming procedure. Peter Cardy, LEADER, Macmillan Cancer Relief, feedback: Our findings are simply the tip of the iceberg. Cancers can have an enormous impact on someone’s income.The 55-gene set targets the GABAergic and glutamatergic systems. The 10-gene set contains useful markers for anatomic delineation. Related StoriesCharles Bonnet syndrome: an interview with Dr. Dominic ffytcheNew study compares performance of clozapine with standard antipsychotics in adults with schizophreniaScalable production of gene therapy vectors: an interview with Frank UbagsIn addition, existing data from what was previously obtainable as the Allen Human Cortex Study have been integrated into the Allen Human Brain Atlas. These data include: 1,000 Gene Survey in Cortex: This ISH study characterizes approximately 1,000 genes in temporal and visual cortex of multiple control cases. Genes included in this dataset represent several categories of wide scientific and clinical interest: cortical cell type markers, gene families vital that you neural function, disease-related genes and genes important in the comparative genomics field.